Team Teaching Heather Stewart & Lori Wilfong State Support Team, Region 4 February 4, 2009.
Pe massive wilfong
-
Upload
pkhohl -
Category
Health & Medicine
-
view
63 -
download
0
description
Transcript of Pe massive wilfong
![Page 1: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/1.jpg)
ALTERED MENTAL STATUS IN A 36 Y/O FJonathan B Wilfong, MD
January 31, 2014
Fletcher Allen Health Care
![Page 2: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/2.jpg)
Admission
36 y/o F is transported to FAHC after being found in bed with altered mental status, responsive only to pain. Per EMS report, two men, one being her husband, were found deceased at the scene with drug paraphernalia scattered close-by. There was no evidence of trauma.
Prior to arrival she was treated with Flumazenil 0.5 mg x2, Naloxone 2 mg IV x4 at a local hospital. She briefly regained consciousness following Flumazenil administration but mental status declined rapidly again. She arrives intubated, off sedation, and is admitted to the MICU for management of hypoxemic respiratory failure.
![Page 3: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/3.jpg)
History
PMH•Substance abuse (benzos, barbituates, IV heroin)•Depression w suicide attempt (overdose, laceration)•Victim of domestic violence•History of imprisonment•Multiple psychiatric (MDD, BPD1, PTSD, ADHD)•Recent aspiration pneumonia in the setting of recent drug overdose
FHx •Unknown
![Page 4: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/4.jpg)
HistoryMedications•busPIRone (BUSPAR) 10 mg tablet •clonAZEPAM (KLONOPIN) 0.5 mg tablet •fluvoxaMINE (LUVOX) 50 mg tablet •montelukast (SINGULAIR) 10 mg tablet •pantoprazole (PROTONIX) 40 mg tablet •Prazosin (MINIPRESS) 2 mg capsule •risperiDONE (RISPERDAL) 1 mg tablet •topiramate (TOPAMAX) 100 mg tablet •albuterol (VENTOLIN HFA) 90 mcg/actuation inhaler •fluticasone-salmeterol (ADVAIR HFA) 45-21 mcg/Actuation inhaler
Allergies•NKDA
![Page 5: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/5.jpg)
Social History• Born in New York, NY• Married, Living in Plattsburg• Married, 3 teenage children in NYC• Known hx of long-standing illicit and Rx drug use
![Page 6: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/6.jpg)
Objective
In the field [AM, Day 1]•62/45•106•20•79% SpO2 on RA
Following intubation, I/O line x2, 2L NS [18:00, Day 1]•105/71•115•29•100% SpO2 on 0.70 FiO2
![Page 7: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/7.jpg)
Initial Evaluation and Work-up
![Page 8: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/8.jpg)
Initial Evaluation and Work-up
142
4.8
97
19
26
1.26130 5.4
11.9
36.8254
AST 87ALT 40tBili 0.3tPro 6.7
24
UASpecGrav 1.02LeukEst negNitrite neg3+ blood
pH 6.0
7.34 / 35 / 94 / 24 on 0.70( PaO2:FiO2 134 )
UTox+ Barbituate+ Benzodiazepine+ Amphetamine
Phenobarbital level 85.5 (15-40) Lactate 3.4
Troponin < 0.034CK 1860
![Page 9: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/9.jpg)
![Page 10: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/10.jpg)
![Page 11: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/11.jpg)
Management• 33.7C , 83/51, 96, 22, GCS 8, ventilated [0:00, Day 2]• Aspiration in the setting of poly-substance use was
suspected.• Pulm: Levofloxacin, Vanc, tapering off ventilator• Cor: IV fluid resuscitation, serial lactate, serial EKG• RenalL: Foley catheter, monitor UOP• Neuro: Head CT negative, Serial neuro exams• GI: NPO• ID: Sputum, Blood, Urine Cx. Abx as above• PPx: PPI, SQ Heparin, SCD
![Page 12: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/12.jpg)
Day of Hospitalization #2• 7.38 / 30 / 60 / 18 on 0.55 (PaO2:FiO2 109) [05:00, Day 2] • Improving mental status, responding to commands
but…• Systolic pressure continued to drop despite 4L IVf
78/46, 138, 33, 98% on 0.60• Levophederine gtt started
The patient was declining despite aggressive supportive care.
![Page 13: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/13.jpg)
Day of Hospitalization #2• Bedside Echocardiogram was performed suggesting RV
ballooning with septal flattening• A STAT CT PE protocol of chest was obtained• A STAT echocardiogram was obtained
![Page 14: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/14.jpg)
![Page 15: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/15.jpg)
![Page 16: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/16.jpg)
CT PE Protocol
CT CHEST W CONTRAST (PE) PROTOCOL 11/1/2013 1:01 PM
Findings: Opacification of the pulmonary vasculature is good. There is a saddle embolus with clot extending predominantly into the lower lobe pulmonary arteries, with the most significant clot burden in the left lower lung. Additional regions of emboli are seen in the right middle lobe There is evidence of right heart strain with a right ventricle to left ventricular ratio of greater than 1.
![Page 17: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/17.jpg)
Echocardiogram
Impressions: Cor pulmonale. Summary: 1. Left ventricle: The cavity size was below normal. … Systolic function was hyperdynamic. The estimated ejection fraction was 65-70%. Wall motion was normal; there were no regional wall motion abnormalities. 2. Ventricular septum: The contour showed diastolic flattening and systolic flattening. 3. Right ventricle: The cavity size was severely dilated. Systolic function was severely reduced. 4. Pulmonary arteries: Pulmonary systolic pressure was moderately increased, estimated to 50mm Hg.
![Page 18: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/18.jpg)
BP 62/45 HR 106RR 20 Found w AMS, Intubated
BP 105/71 HR 115RR 29Stable,Arrives at FAHC
BP 83/51 HR 96RR 22MICU, Improving mental status
BP 78/46 HR 138RR 33Declining mental status
IntubatedIV access2L NS
FlumazenilNaloxone
2L NSCentral lineLevofloxacin
LevophedVancomycin
Bedside echo
CTangio TPA
0:0012:00 12:00
Echo
Transfer
Phenylepherine added
0:00
BP 86/47 HR 128RR 26Unresponsive
CT Head
![Page 19: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/19.jpg)
PULMONARY EMBOLISM IN THE SETTING OF CRITICAL ILLNESS
![Page 20: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/20.jpg)
Overview
• Incidence• Pathophysiology• Diagnosis• Treatment• Outcomes
![Page 21: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/21.jpg)
Incidence• “Obstruction of the pulmonary artery or one of its
branches by material (eg, thrombus, tumor, air, or fat) that originated elsewhere”• Massive = sustained hypotension
• 112.3 per 100,000• Mortality estimated 30% if untreated• Risk factors
• Immobilization• Obesity, Heart Disease• Malignancy, Autoimmune• Central venous instrumentation, Surgery• Smoking, Medications
![Page 22: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/22.jpg)
Pathophysiology• 50-80% from below popliteal vein• Severe acute VQ mismatch• Death is by R heart failure, acute cardiogenic shock• Increase in mortality from PE and overall
• RV strain • Mural thrombus• DVT
• Associated w increased mortality• BNP• Troponin• Hyponatremia• Lactate
![Page 23: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/23.jpg)
Diagnosis• Clinical findings nonspecific
• DVT signs (47%)
• Diagnostic studies• S1Q3T3 on ECG suggestive of cor pulmonale• Lower extremity US for risk reduction – not diagnosis• VQ scan 15-86% diagnostic accuracy• D-Dimer high negative predictive value• CT angiogram, 53-98% diagnostic accuracy
• Echocardiogram• Increased RV size• TR• Mural thrombus• McConnell sign (hypokinesis w apical sparing)
![Page 24: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/24.jpg)
Echocardiogram• http://www.youtube.com/watch?v=x4bVhnL3Ix8
![Page 25: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/25.jpg)
Treatment: A Simplified Algorithm
1. Stabilize
2. Anticoagulate
3. Unstable? Thrombolysis
4. Unimproved? Consider Embolectomy
![Page 26: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/26.jpg)
Treatment of Acute Massive PE• Correction of hypoxemia• Hemodynamic Support
• IV fluids, 500-1000 mL• Pressors: NorEpi/Epi/Dobutamine
• Empiric Anticoagulation within 24hr• Weigh against risk of acute bleed (recurrent PE 25% > Bleed 3%)• LMWH as tx in uncomplicated cases• IV UFH if massive PE, risk of bleed, or considering lysis, thrombectomy
![Page 27: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/27.jpg)
Dosing IV UFH• Bolus 80 mg/kg• Infusion 18 mg/hr• Titrate to institution protocol goal aPTT• If abnormal PTT response
• Follow anti-Xa
• When to consider thrombolysis?
![Page 28: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/28.jpg)
Thrombolysis• Indication:
• persisting SHOCK• Isolated RV dysfunction..?
• Outcomes:• Early hemodynamic improvement• No proven mortality benefit
• (3.5 vs 6.1 percent, relative risk 0.7, 95% CI 0.37-1.31)
• Increased risk of major bleeding• (9.0 vs 5.7 percent, relative risk 1.63, 95% CI 1.00-2.68)• Risks for bleeding not well characterized• Intracranial hemorrhage rate ~3%
![Page 29: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/29.jpg)
Contraindications• Surgery in last 10 days• Bleeding diathesis• Intracranial neoplasm• Severe HTN (>200)• Ischemic stroke within 2 months• Past hemorrhagic stroke• Intracranial trauma/surgery in last 6 months• Thrombocytopenia (<100k)
![Page 30: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/30.jpg)
tPA Dosing• Binds Fibrin affinity for Plasminogin activation• Administration
• Stop Heparin• tPA 100 mg IV infusion over 2 hr• Re-check aPTT• Restart anticoagulation
• Reassess hemodynamics routinely
![Page 31: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/31.jpg)
Thrombectomy• Catheter
• Interventional Radiology• Limited data• Requires vascular access with chance of bleeding• High intraoperative mortality
• Open Surgical• High mortality• Requires cardiopulmonary bypass• High rate of intraoperative myocardial infarction• No evidence of better outcomes than repeat tPA
• Lower risk of severe bleeding?
![Page 32: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/32.jpg)
Our patient• tPA was administered with little to no benefit at four hours• Surgical thrombectomy not available at FAHC• Urgently transferred by air to Brigham and Womens • Repeat CT showed migration of thrombus• Supportive care continued in MICU
![Page 33: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/33.jpg)
Bedside echo
![Page 34: Pe massive wilfong](https://reader033.fdocuments.net/reader033/viewer/2022061304/5497ecaeac795959288b561b/html5/thumbnails/34.jpg)
Take Away• Think PE on the DDx for cardiogenic shock• Bedside US can aid in diagnosis• Urgent anticoagulation with IV UFH• There are 8 strict contraindications to tPA• No evidence of improved mortality w tPA• Surgical thrombectomy as a last resort